Resolving Inflammation in Heart Failure: Novel Protective Lipid Mediators

Author(s): Marta Reina-Couto, Luís Vale, Jorge Carvalho, Paulo Bettencourt, António Albino-Teixeira, Teresa Sousa.

Journal Name: Current Drug Targets

Volume 17 , Issue 10 , 2016

  Journal Home
Translate in Chinese
Become EABM
Become Reviewer


Inflammation is an important pathogenic mechanism in chronic heart failure (HF). The perpetuation of the inflammatory response in this syndrome may result either from excessive activation of proinflammatory cascades or disturbances in the resolution of inflammation. However, although cardiovascular research has extensively investigated the proinflammatory processes involved in chronic HF pathophysiology, the mechanisms responsible for inflammation resolution in this disease remain largely disregarded. The resolving response is currently considered an active process involving specific effectors that limit the progression of inflammation and promote tissue regeneration. This article aims at reviewing the major classes of lipid mediators of inflammation resolution, their cardiovascular, metabolic and renal protective effects that might putatively delay the onset and progression of chronic HF, and their therapeutic modulation. Furthermore, it also aims to emphasize the importance of adopting therapeutic strategies that stimulate the resolution of inflammation in chronic HF.

Keywords: Heart failure, resolution of inflammation, proresolving lipid mediators, cardiovascular/metabolic and renal protection, therapeutic modulation.

Rights & PermissionsPrintExport Cite as

Article Details

Year: 2016
Page: [1206 - 1223]
Pages: 18
DOI: 10.2174/1389450117666160101121135
Price: $58

Article Metrics

PDF: 28
PRC: 1